Literature DB >> 23197383

Assessing the fit of parametric cure models.

E Paul Wileyto1, Yimei Li, Jinbo Chen, Daniel F Heitjan.   

Abstract

Survival data can contain an unknown fraction of subjects who are "cured" in the sense of not being at risk of failure. We describe such data with cure-mixture models, which separately model cure status and the hazard of failure among non-cured subjects. No diagnostic currently exists for evaluating the fit of such models; the popular Schoenfeld residual (Schoenfeld, 1982. Partial residuals for the proportional hazards regression-model. Biometrika 69, 239-241) is not applicable to data with cures. In this article, we propose a pseudo-residual, modeled on Schoenfeld's, to assess the fit of the survival regression in the non-cured fraction. Unlike Schoenfeld's approach, which tests the validity of the proportional hazards (PH) assumption, our method uses the full hazard and is thus also applicable to non-PH models. We derive the asymptotic distribution of the residuals and evaluate their performance by simulation in a range of parametric models. We apply our approach to data from a smoking cessation drug trial.

Entities:  

Mesh:

Year:  2012        PMID: 23197383      PMCID: PMC3695652          DOI: 10.1093/biostatistics/kxs043

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  9 in total

1.  Estimation in a Cox proportional hazards cure model.

Authors:  J P Sy; J M Taylor
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Modelling survival data with a cured fraction using frailty models.

Authors:  D L Price; A K Manatunga
Journal:  Stat Med       Date:  2001 May 15-30       Impact factor: 2.373

3.  On the use and utility of the Weibull model in the analysis of survival data.

Authors:  Kevin J Carroll
Journal:  Control Clin Trials       Date:  2003-12

4.  Estimating and modeling the cure fraction in population-based cancer survival analysis.

Authors:  Paul C Lambert; John R Thompson; Claire L Weston; Paul W Dickman
Journal:  Biostatistics       Date:  2006-10-04       Impact factor: 5.899

5.  A generalized F mixture model for cure rate estimation.

Authors:  Y Peng; K B Dear; J W Denham
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

6.  The use of mixture models for the analysis of survival data with long-term survivors.

Authors:  V T Farewell
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

7.  Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion.

Authors:  E Paul Wileyto; Freda Patterson; Raymond Niaura; Leonard H Epstein; Richard A Brown; Janet Audrain-McGovern; Larry W Hawk; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2005-04       Impact factor: 4.244

8.  Modeling smoking cessation data with alternating states and a cure fraction using frailty models.

Authors:  Yimei Li; E Paul Wileyto; Daniel F Heitjan
Journal:  Stat Med       Date:  2010-03-15       Impact factor: 2.373

9.  Establishing long-term survival and cure in young patients with Ewing's sarcoma.

Authors:  C L Weston; C Douglas; A W Craft; I J Lewis; D Machin
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  9 in total
  15 in total

1.  Concordance measure and discriminatory accuracy in transformation cure models.

Authors:  Yilong Zhang; Yongzhao Shao
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

2.  Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools.

Authors:  Sebastiaan C Goulooze; Elke H J Krekels; Thomas Hankemeier; Catherijne A J Knibbe
Journal:  AAPS J       Date:  2018-12-18       Impact factor: 4.009

3.  Platelet microRNA for predicting acute myocardial infarction.

Authors:  Shuhua Li; Long Zhe Guo; Moo Hyun Kim; Jin-Yeong Han; Victor Serebruany
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

4.  Exposure assessment for Cox proportional hazards cure models with interval-censored survival data.

Authors:  Wei Wang; Ning Cong; Aijun Ye; Hui Zhang; Bo Zhang
Journal:  Biom J       Date:  2021-08-10       Impact factor: 2.207

5.  Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.

Authors:  Huiyan Luo; Jin Lu; Yuxian Bai; Teng Mao; Jun Wang; Qingxia Fan; Yiping Zhang; Kuaile Zhao; Zhendong Chen; Shegan Gao; Jiancheng Li; Zhichao Fu; Kangsheng Gu; Zhihua Liu; Lin Wu; Xiaodong Zhang; Jifeng Feng; Zuoxing Niu; Yi Ba; Helong Zhang; Ying Liu; Li Zhang; Xuhong Min; Jing Huang; Ying Cheng; Dong Wang; Yu Shen; Qing Yang; Jianjun Zou; Rui-Hua Xu
Journal:  JAMA       Date:  2021-09-14       Impact factor: 56.272

6.  Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.

Authors:  Xi Wang; Shu-Sen Wang; Heng Huang; Li Cai; Li Zhao; Rou-Jun Peng; Ying Lin; Jun Tang; Jian Zeng; Le-Hong Zhang; Yong-Li Ke; Xian-Ming Wang; Xin-Mei Liu; Qian-Jun Chen; An-Qin Zhang; Fei Xu; Xi-Wen Bi; Jia-Jia Huang; Ji-Bin Li; Dan-Mei Pang; Cong Xue; Yan-Xia Shi; Zhen-Yu He; Huan-Xin Lin; Xin An; Wen Xia; Ye Cao; Ying Guo; Yan-Hong Su; Xin Hua; Xin-Yue Wang; Ruo-Xi Hong; Kui-Kui Jiang; Chen-Ge Song; Zhang-Zan Huang; Wei Shi; Yong-Yi Zhong; Zhong-Yu Yuan
Journal:  JAMA       Date:  2021-01-05       Impact factor: 56.272

7.  Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts.

Authors:  Zhiwei Li; Shengmin Mei; Jie Xiang; Jie Zhou; Qijun Zhang; Sheng Yan; Lin Zhou; Zhenhua Hu; Shusen Zheng
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

8.  Clinical outcomes of theophylline use as add-on therapy in patients with chronic obstructive pulmonary disease: A propensity score matching analysis.

Authors:  Preyanate Wilairat; Kirati Kengkla; Chaiyawat Thayawiwat; Phongsathorn Phlaisaithong; Supakorn Somboonmee; Surasak Saokaew
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

9.  Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database.

Authors:  Jie Zhou; Zhichao Huang; Zheng Chen; Fangshen Xu; Rongliang Tong; Shusen Zheng
Journal:  BMC Gastroenterol       Date:  2021-04-30       Impact factor: 3.067

10.  A Comparison between Cure Model and Recursive Partitioning: A Retrospective Cohort Study of Iranian Female with Breast Cancer.

Authors:  Mozhgan Safe; Javad Faradmal; Hossein Mahjub
Journal:  Comput Math Methods Med       Date:  2016-08-28       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.